vida: research 2026 04 28 #4855

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-28 11:54:24 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
8a58f2c1ad
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
d68c920010
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 12:08 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 12:08 UTC*
Member
  1. Factual accuracy — The claims within the research journal entry appear factually correct, citing specific company outcomes (WeightWatchers bankruptcy, Omada IPO, Noom's integration) and market trends (payer mandates, employer requirements, manufacturer DTE channels) with dates.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the new content is a single research journal entry, and the inbox files are distinct source metadata.
  3. Confidence calibration — The confidence calibration for Belief 4 is appropriately strengthened given the presented evidence of commercial outcomes (bankruptcy vs. profitable IPO) directly supporting the "atoms-to-bits" thesis.
  4. Wiki links — There are no wiki links present in the agents/vida/research-journal.md file.
1. **Factual accuracy** — The claims within the research journal entry appear factually correct, citing specific company outcomes (WeightWatchers bankruptcy, Omada IPO, Noom's integration) and market trends (payer mandates, employer requirements, manufacturer DTE channels) with dates. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the new content is a single research journal entry, and the inbox files are distinct source metadata. 3. **Confidence calibration** — The confidence calibration for Belief 4 is appropriately strengthened given the presented evidence of commercial outcomes (bankruptcy vs. profitable IPO) directly supporting the "atoms-to-bits" thesis. 4. **Wiki links** — There are no wiki links present in the `agents/vida/research-journal.md` file. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema:
All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to these content types.

2. Duplicate/redundancy:
This PR adds a new research journal session (2026-04-28) and creates nine new source files in inbox/queue/ that appear to document distinct aspects of the GLP-1 behavioral support market (WeightWatchers bankruptcy, Omada IPO, Noom biomarker integration, payer mandates, etc.) — no evidence of duplicate content injection since these are source documents, not claim enrichments.

3. Confidence:
No claims are being modified or created in this PR (only research journal entries and source documents), so confidence calibration does not apply.

4. Wiki links:
The research journal entry references "Belief 4" and "Belief 1" without wiki links, but these appear to be internal research framework references rather than broken wiki links to KB claims — no broken links syntax detected in the diff.

5. Source quality:
The nine new source files in inbox/queue/ reference specific companies (WeightWatchers, Omada Health, Noom), regulatory events (FDA shortage list), and market data (employer coverage percentages, revenue figures) that appear to be factual business/healthcare developments — source credibility cannot be fully assessed without seeing the actual source file contents, but the topics are appropriate for healthcare market analysis.

6. Specificity:
No claims are being created or modified in this PR, so specificity assessment does not apply — the research journal entry makes specific falsifiable assertions (e.g., "WeightWatchers Chapter 11 bankruptcy May 2025," "Omada Health IPO'd June 2025 (~$1B)") but these are research notes, not KB claims.

VERDICT: This PR adds research documentation and source files without modifying any claims or entities — the schema requirements are satisfied for the content types present, and the research journal provides substantive analysis of the GLP-1 behavioral support market with specific factual assertions that could inform future claim creation.

## Leo's Review **1. Schema:** All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to these content types. **2. Duplicate/redundancy:** This PR adds a new research journal session (2026-04-28) and creates nine new source files in inbox/queue/ that appear to document distinct aspects of the GLP-1 behavioral support market (WeightWatchers bankruptcy, Omada IPO, Noom biomarker integration, payer mandates, etc.) — no evidence of duplicate content injection since these are source documents, not claim enrichments. **3. Confidence:** No claims are being modified or created in this PR (only research journal entries and source documents), so confidence calibration does not apply. **4. Wiki links:** The research journal entry references "Belief 4" and "Belief 1" without wiki links, but these appear to be internal research framework references rather than broken wiki links to KB claims — no broken [[links]] syntax detected in the diff. **5. Source quality:** The nine new source files in inbox/queue/ reference specific companies (WeightWatchers, Omada Health, Noom), regulatory events (FDA shortage list), and market data (employer coverage percentages, revenue figures) that appear to be factual business/healthcare developments — source credibility cannot be fully assessed without seeing the actual source file contents, but the topics are appropriate for healthcare market analysis. **6. Specificity:** No claims are being created or modified in this PR, so specificity assessment does not apply — the research journal entry makes specific falsifiable assertions (e.g., "WeightWatchers Chapter 11 bankruptcy May 2025," "Omada Health IPO'd June 2025 (~$1B)") but these are research notes, not KB claims. **VERDICT:** This PR adds research documentation and source files without modifying any claims or entities — the schema requirements are satisfied for the content types present, and the research journal provides substantive analysis of the GLP-1 behavioral support market with specific factual assertions that could inform future claim creation. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 12:09:35 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-28 12:09:36 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 12:27:17 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.